AstraZeneca has recently completed a significant clinical study titled ‘A Multicenter, Single-arm, Open-label, Post-Authorization, Phase 4 Effectiveness and Safety Study of Tezepelumab in Adult and ...

A new “wonder drug” injection for uncontrolled asthma has been approved for use on the NHS. The National Institute for Health and Care Excellence (Nice) has recommended dupilumab for some patients ...

A medication used to treat asthma can now be used to help people with food allergies avoid severe reactions, the U.S. Food and Drug Administration said Friday. Xolair, the brand name for the drug ...

Fasenra is an injected medication that helps prevent severe asthma attacks (exacerbations) and may improve your breathing. Fasenra reduces blood eosinophils. About 50% of people with severe asthma ...

OKLAHOMA CITY (KFOR) — Next month, Oklahomans with severe asthma who are insured with BlueCross and BlueShield of Oklahoma (BCBSOK), may have to give themselves life-saving shots at home after a ...

MISSISSAUGA, ON, Nov. 17, 2020 /CNW/ - Sanofi Canada announced today that Health Canada approved a new indication for DUPIXENT ® (dupilumab injection), for adults and adolescents aged 12 years and ...

The ATHENA Study, officially titled ‘ItAlian, Multicenter, Observational, Prospective sTudy to Evaluate the acHievement of Clinical rEmission and immuNomodulation in Severe Eosinophilic Asthma ...

Blue Cross Blue Shield (BCBS), under its parent company Health Care Service Corporation, is changing how certain asthma injections are administered. Effective April 15, 2025, some patients will need ...

MISSISSAUGA, ON, Feb. 26, 2018 /CNW/ - AstraZeneca Canada today announced that Health Canada has approved Fasenra ® (benralizumab injection) as an add-on maintenance treatment for adult patients with ...

Fewer than half of asthma patients think their condition is managed well, according to a new study sponsored by asthma drug maker GSK and conducted by creative think tank Economist Impact. The result ...

The National Institute for Health and Care Excellence (NICE) is recommending the injectable biologic dupilumab (Dupixent, Sanofi) as a maintenance therapy for uncontrolled asthma as an alternative to ...

Oklahoma's largest health insurer recently made a drastic change that will limit treatment options for people battling severe asthma.Blue Cross Blue Shield of Oklahoma, which covers more than 800,000 ...